Top News Stories
News
FDA approves $2.1 million gene therapy drug
By James Paton and Michelle Fay CortezZolgensma, the first drug in the U.S. to cross the $1 million mark, is an important test for the field as a wave of gene therapies advance.
Zolgensma, the first drug in the U.S. to cross the $1 million mark, is an important test for the field as a wave of gene therapies advance.